Share-Based Expense |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Payment Arrangement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-Based Expense |
Total share-based expense related to stock options, restricted stock units (“RSUs”) and common stock awards was approximately $ million during the three months ended September 30, 2021 and 2020 and approximately $ million and $ million for the nine months ended September 30, 2021 and 2020, respectively.
Share-based compensation expense is classified in the condensed consolidated statements of operations as follows:
Employee Stock Options
During the nine months ended September 30, 2021, the Company granted the Company’s stock price, a risk free rate of There were no employee stock options or RSUs granted or exercised during the nine months ended September 30, 2020. The Company recognized a total of $ %, an expected life of years and an expected volatility rate of %. million of compensation expense related to employee stock options during the three months ended September 30, 2021 and 2020 and $ million and $ million during the nine months ended September 30, 2021 and 2020, respectively. stock option awards to purchase shares of common stock. The weighted average grant date fair value per option share was $ . Key assumptions used in the Black-Scholes option pricing model for options granted during the nine months ending September 30, 2021 were
Non-Employee Stock Options
The Company did not grant any non-employee stock options during the three and nine months ended September 30, 2021 and 2020. The Company did not recognize any expense related to non-employee stock options during the three and nine months ended September 30, 2021. The Company recognized approximately $ and $ of expense during the three and nine months ended September 30, 2020, respectively.
Common Stock Awards
The Company did not grant any common stock awards during the three and nine months ended September 30, 2021 and September 30, 2020, respectively. During the three and nine months ended September 30, 2021, the Company issued 253 common stock awards authorized but not issued. shares related to common stock awards. During the nine months ended September 30, 2020, the Company issued shares related to common stock awards. As of September 30, 2021, there were |